HCW Biologics (HCWB) Cash from Operations (2020 - 2025)
HCW Biologics' (HCWB) quarterly Cash from Operations came in at 3355517.0 in Q4 2025, down 18.37% YoY from 4110408.1 in Q4 2024, and down 3.57% on a QoQ basis from 3239941.0 in Q3 2025.
HCW Biologics (HCWB) Cash from Operations (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Cash from Operations data on file, last reported at 3355517.0 in Q4 2025.
- Quarterly Cash from Operations fell 18.37% year-over-year to 3355517.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 13391617.0 (up 5.87% YoY) and the FY2025 annual result came in at 13391617.0, up 5.87% from the prior year.
- Cash from Operations retreated to 3355517.0 in Q4 2025, from 3239941.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 990440.0 in Q2 2021 to a low of 9391846.0 in Q2 2023.
- A 5-year average of 3574749.65 and a median of 3366055.5 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations surged 54.78% — and 2023, when it tumbled 249.16%.
- Tracing HCWB's Cash from Operations over 5 years: stood at 3376594.0 in 2021, then decreased by 12.22% to 3789371.0 in 2022, then declined by 2.78% to 3894792.0 in 2023, then grew by 27.21% to 2834881.0 in 2024, then slipped by 18.37% to 3355517.0 in 2025.
- The last three Cash from Operations figures came in at 3355517.0 (Q4 2025), 3239941.0 (Q3 2025), and 3282303.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.36 Mn |
| Dec 31, 2025 | -3.36 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | -3.51 Mn |
| Mar 31, 2025 | -3.51 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -4.86 Mn |
| Jun 30, 2024 | -4.86 Mn |
| Mar 31, 2024 | -3.60 Mn |
| Mar 31, 2024 | -3.60 Mn |
| Dec 31, 2023 | -3.89 Mn |
| Dec 31, 2023 | -3.89 Mn |
| Sep 30, 2023 | -5.59 Mn |
| Sep 30, 2023 | -5.59 Mn |